Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala

Psychoneuroendocrinology

Volumn 40, Issue 1, 2014, Pages 17-26

  Arendt, David H ^a,b,c,e   Hassell, James ^b   Li, Hao ^b   Achua, Justin K ^b,c,e   Guarnieri, Douglas J ^f   DiLeone, Ralph J ^f   Ronan, Patrick J ^c,d,e   Summers, Cliff H ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b W O Farber Center for Civic Leadership   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

^d Avera Research Institute   (United States)

^e Research Service   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Anxiety; Basolateral amygdala; Hypocretin; Knockdown; Orexin; Orexin 2 receptor; ShRNA

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN RECEPTOR; SHORT HAIRPIN RNA;

ADENO ASSOCIATED VIRUS; ADULT; ANIMAL EXPERIMENT; ANXIETY; ANXIETY DISORDER; ARTICLE; BASOLATERAL AMYGDALA; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; FORCED SWIM TEST; GENE EXPRESSION; GENE SEQUENCE; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC CORTEX; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PANIC; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SUCROSE PREFERENCE TEST; TRANQUILIZING ACTIVITY;

AMYGDALA; ANXIETY; BASOLATERAL AMYGDALA; HYPOCRETIN; KNOCKDOWN; OREXIN; OREXIN 2 RECEPTOR; SHRNA;

AMYGDALA; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DOMINANCE-SUBORDINATION; FEAR; MALE; MICE; MICE, INBRED C57BL; OREXIN RECEPTORS; RESILIENCE, PSYCHOLOGICAL; RNA, SMALL INTERFERING;

EID: 84893393008     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.10.010     Document Type: Article

References (51)

1. Akbari E., Motamedi F., Davoodi F.G., Noorbakhshnia M., Ghanbarian E. Orexin-1 receptor mediates long-term potentiation in the dentate gyrus area of freely moving rats. Behav. Brain Res. 2011, 216:375-380.
2. Arendt D.H., Ronan P.J., Oliver K.D., Callahan L.B., Summers T.R., Summers C.H. Depressive behavior and activation of the orexin/hypocretin system. Behav. Neurosci. 2013, 127:86-94.
3. Avolio E., Alo R., Carelli A., Canonaco M. Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster. Behav. Brain Res. 2011, 218:288-295.
4. Barot S.K., Chung A., Kim J.J., Bernstein I.L. Functional imaging of stimulus convergence in amygdalar neurons during Pavlovian fear conditioning. PLoS ONE 2009, 4:e6156.
5. Bernard R., Lydic R., Baghdoyan H.A. Hypocretin-1 causes G protein activation and increases ACh release in rat pons. Eur. J. Neurosci. 2003, 18:1775-1785.
6. Bisetti A., Cvetkovic V., Serafin M., Bayer L., Machard D., Jones B.E., Muhlethaler M. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 2006, 142:999-1004.
7. Canteras N.S., Resstel L.B., Bertoglio L.J., Carobrez Ade P., Guimaraes F.S. Neuroanatomy of anxiety. Curr. Top. Behav. Neurosci. 2010, 2:77-96.
8. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:322-327.
9. Deadwyler S.A., Porrino L., Siegel J.M., Hampson R.E. Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J. Neurosci. 2007, 27:14239-14247.
10. Dhuria S.V., Hanson L.R., Frey W.H. Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system. J. Pharm. Sci. 2009, 98:2501-2515.
11. Dhuria S.V., Hanson L.R., Frey W.H. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system. J. Pharmacol. Exp. Ther. 2009, 328:312-320.
12. Hoang Q.V., Bajic D., Yanagisawa M., Nakajima S., Nakajima Y. Effects of orexin (hypocretin) on GIRK channels. J. Neurophysiol. 2003, 90:693-702.
13. Hommel J.D., Sears R.M., Georgescu D., Simmons D.L., DiLeone R.J. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 2003, 9:1539-1544.
14. Johnson P., Molosh A., Truitt W., Shekhar A. Orexin, stress and anxiety/panic states. Prog. Brain Res. 2012, 198:133-161.
15. Johnson P.L., Samuels B.C., Fitz S.D., Lightman S.L., Lowry C.A., Shekhar A. Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology 2012, 37:1911-1922.
16. Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., Traskman-Bendz L., Goddard A.W., Brundin L., Shekhar A. A key role for orexin in panic anxiety. Nat. Med. 2010, 16:111-115.
17. Karteris E., Machado R.J., Chen J., Zervou S., Hillhouse E.W., Randeva H.S. Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E1089-E1100.
18. Kayaba Y., Nakamura A., Kasuya Y., Ohuchi T., Yanagisawa M., Komuro I., Fukuda Y., Kuwaki T. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R581-R593.
19. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 2003, 289:3095-3105.
20. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
21. Kida S. A functional role for CREB as a positive regulator of memory formation and LTP. Exp. Neurobiol. 2012, 21:136-140.
22. Krettek J.E., Price J.L. A description of the amygdaloid complex in the rat and cat with observations on intra-amygdaloid axonal connections. J. Comp. Neurol. 1978, 178:255-280.
23. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
24. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. Am. J. Psychiatry 2010, 167:1305-1320.
25. Kukkonen J.P. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am. J. Physiol. Cell Physiol. 2013, 304:C2-C32.
26. Li Y., Li S., Wei C., Wang H., Sui N., Kirouac G.J. Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) 2010, 212:251-265.
27. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δδC(T)) method. Methods 2001, 25:402-408.
29. Lutter M., Krishnan V., Russo S.J., Jung S., McClung C.A., Nestler E.J. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J. Neurosci. 2008, 28:3071-3075.
30. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 2001, 435:6-25.
31. Miller M.M., Morrison J.H., McEwen B.S. Basal anxiety-like behavior predicts differences in dendritic morphology in the medial prefrontal cortex in two strains of rats. Behav. Brain Res. 2012, 229:280-288.
32. Nollet M., Gaillard P., Minier F., Tanti A., Belzung C., Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 2011, 61:336-346.
33. Nollet M., Leman S. Role of orexin in the pathophysiology of depression: potential for pharmacological intervention. CNS Drugs 2013, 27:411-422.
34. Orsini C.A., Maren S. Neural and cellular mechanisms of fear and extinction memory formation. Neurosci. Biobehav. Rev. 2012, 36:1773-1802.
35. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
36. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
37. Ressler K.J., Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat. Neurosci. 2007, 10:1116-1124.
38. Rodgers R.J., Wright F.L., Snow N.F., Taylor L.J. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naive or plus-maze-experienced mice. Behav. Brain Res. 2013, 243C:213-219.
39. Sajdyk T.J., Shekhar A. Excitatory amino acid receptors in the basolateral amygdala regulate anxiety responses in the social interaction test. Brain Res. 1997, 764:262-264.
40. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92. 1 page following 696.
41. Sakurai T., Nagata R., Yamanaka A., Kawamura H., Tsujino N., Muraki Y., Kageyama H., Kunita S., Takahashi S., Goto K., Koyama Y., Shioda S., Yanagisawa M. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005, 46:297-308.
42. Scott M.M., Marcus J.N., Pettersen A., Birnbaum S.G., Mochizuki T., Scammell T.E., Nestler E.J., Elmquist J.K., Lutter M. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav. Brain Res. 2011, 222:289-294.
43. Sharf R., Sarhan M., Brayton C.E., Guarnieri D.J., Taylor J.R., DiLeone R.J. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol. Psychiatry 2010, 67:753-760.
44. Steiner M.A., Lecourt H., Jenck F. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. Psychopharmacology (Berl) 2012, 223:465-475.
45. Suzuki M., Beuckmann C.T., Shikata K., Ogura H., Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res. 2005, 1044:116-121.
46. Tannure R.M., Bittencourt A.S., Schenberg L.C. Short-term full kindling of the amygdala dissociates natural and periaqueductal gray-evoked flight behaviors of the rat. Behav. Brain Res. 2009, 199:247-256.
47. Tye K.M., Prakash R., Kim S.Y., Fenno L.E., Grosenick L., Zarabi H., Thompson K.R., Gradinaru V., Ramakrishnan C., Deisseroth K. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471:358-362.
48. Vidal-Gonzalez I., Vidal-Gonzalez B., Rauch S.L., Quirk G.J. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn. Mem. 2006, 13:728-733.
49. Wall V.L., Fischer E.K., Bland S.T. Isolation rearing attenuates social interaction-induced expression of immediate early gene protein products in the medial prefrontal cortex of male and female rats. Physiol. Behav. 2012, 107:440-450.
50. Wallace T.L., Stellitano K.E., Neve R.L., Duman R.S. Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biol. Psychiatry 2004, 56:151-160.
51. Yehuda R., Teicher M.H., Trestman R.L., Levengood R.A., Siever L.J. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry 1996, 40:79-88.